Variantyx provides whole‑genome sequencing on a single platform that delivers both targeted gene panels and automatic reflex to comprehensive analysis without additional samples. Their AI/ML‑driven pipeline detects a broad spectrum of variant types—including structural rearrangements and repeat expansions—to achieve high diagnostic yield for rare diseases, prenatal genetics, and precision oncology. The service includes CLIA‑ and CAP‑certified lab processing, flexible billing, and clinical support for laboratories and specialty physicians.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with rare genetic disorders, reproductive concerns, or cancer often undergo multiple sequential tests that may miss complex variants, leading to prolonged diagnostic journeys and delayed treatment decisions.
Solution
Variantyx offers whole‑genome sequencing performed on a single platform that can deliver both targeted gene panels and comprehensive analyses. The workflow allows an initial targeted test to automatically reflex to a full genome analysis without requiring additional samples, ensuring that non‑diagnostic results are quickly expanded to a broader search. Proprietary AI/ML algorithms interpret the data to identify a wide range of variant types, including structural rearrangements and repeat expansions that conventional assays may overlook. Results are delivered with a focus on high diagnostic yield, streamlined billing, and integrated clinical support to accelerate personalized care.
Target Audience
Primary customers are clinical laboratories, hospitals, and specialty physicians (geneticists, oncologists, reproductive specialists) who require comprehensive, high‑yield genomic testing for rare disease diagnosis, prenatal assessment, and precision oncology.
Features
- Whole‑genome sequencing platform supporting both targeted panels and reflex to comprehensive analysis from the same sample
- AI/ML‑driven variant detection pipeline capable of identifying SNVs, indels, copy‑number changes, inversions, and repeat expansions
- Flexible reflex options that automatically expand testing when initial results are non‑diagnostic, eliminating repeat sampling
- CLIA‑ and CAP‑certified laboratory with multiple state licenses ensuring regulatory compliance
- Acceptance of diverse specimen types (blood, saliva, gDNA, amniotic fluid, CVS, FFPE, etc.) for pediatric, prenatal, oncology, and wellness testing
- Integrated case studies and webinars to support clinicians in interpreting complex genomic findings